Useful Contacts

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-09-02-2007
Volume 31
Issue 9

Useful Contacts

Useful Contacts

Indian Drug Manufacturers' Association (IDMA)

Mumbai

www.idma-assn.org,

tel. +91 22 2494 4624

Indian Pharmaceutical Association (IPA)

Mumbai

www.ipapharma.org,

tel: +91 22 2667 0742

Indian Pharma Machinery Manufacturers' Association (IPMMA)

Mumbai

www.ipmma.org,

tel: +91 22 2578 6007

Organization of Pharmaceutical Producers of India (OPPI)

Mumbai,

www.indiaoppi.com

Pharmaceuticals Export Promotion Council (Pharmexcil)

Hyderabad

www.pharmexcil.com,

tel: +91 40 2373 5462

For further information about the above companies, please email info@ecreviews.com or log on to ecreviews.com.

Articles in this issue
i4-455291-1408664386293.jpg
Advances in Asymmetric Synthesis
i1-455290-1408664389819.jpg
A Call for FDA Inspections
i1-455288-1408664393262.jpg
CMOs Join Pharma Facility Swap Meet
Supplements to the PQRI Workshop Results
i1-454947-1408664807148.jpg
How to Gain Approval Overseas
Pharma Capsules
i1-455287-1408664395306.jpg
Printing Digital Labels
i3_t-455286-1408664397850.jpg
Enhancing Drug Safety
i17_t-454945-1408664815843.gif
Lubrication of Direct-Compressible Blends with Magnesium Stearate Monohydrate and Dihydrate
i1-454948-1408664805478.jpg
The Challenges and Opportunities in ICH Q10
i1-452988-1408666904821.jpg
Case Studies
Revolution in Progress
ICH-Q10: A Recipe for the Product Life Cycle
ICH-Q10: A Recipe for the Product Life Cycle
i4-452935-1408667004344.jpg
Profiles in Biotechnology, Standards, Machinery, Innovation, Global Know-how, Strategies, and Expansion
Useful Contacts
Recent Videos
Roger Viney from ICE Pharma discusses the quality and compliance issues surrounding the use of animal-derived ingredients in the bio/pharma industry.
Tore Bergsteiner from MAIN5 discusses the most pertinent and impactful bio/pharma industry trends from 2024.
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Benuvia Awarded NIH Contract for GMP Synthesis of Psilocybin, Other Drug Substances

Patrick Lavery
March 25th 2025
Article

The contract will support R&D of high-quality APIs for substance use disorders and mental health conditions, starting with synthesis and scale-up of psilocybin, which is derived from mushrooms.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

TOP NEWS on grunge world map | Image Credit: © Sean K - stock.adobe.com

EMA and HMA Publish Joint Network Strategy to 2028

Patrick Lavery
March 24th 2025
Article

The EU medicines agencies’ network strategy, EMANS, is an update of the five-year strategy previously developed to cover the period 2021 to 2025.

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
May 28th 2024
Podcast

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

ITT Brands’ Industry 4.0 Solutions for Flow Control to Be Shown at INTERPHEX

Patrick Lavery
March 21st 2025
Article

Upgraded and dynamic valve platforms as well as advanced sensing will be some of the components of ITT’s exhibit.

TOP NEWS on grunge world map | Image Credit: © Sean K - stock.adobe.com

SGD Pharma Details Latest Sustainability Investments at DCAT Week 2025

Patrick Lavery
March 19th 2025
Article

The company is highlighting its commitment to next-generation glass manufacturing in efforts to strengthen the pharmaceutical supply chain.